Literature DB >> 25934358

D-dimer: An Overview of Hemostasis and Fibrinolysis, Assays, and Clinical Applications.

John D Olson1.   

Abstract

D-dimer is the smallest fibrinolysis-specific degradation product found in the circulation. The origins, assays, and clinical use of D-dimer will be addressed. Hemostasis (platelet and vascular function, coagulation, fibrinolysis, hemostasis) is briefly reviewed. D-dimer assays are reviewed. The D-dimer is very sensitive to intravascular thrombus and may be markedly elevated in disseminated intravascular coagulation, acute aortic dissection, and pulmonary embolus. Because of its exquisite sensitivity, negative tests are useful in the exclusion venous thromboembolism. Elevations occur in normal pregnancy, rising two- to fourfold by delivery. D-dimer also rises with age, limiting its use in those >80 years old. There is a variable rise in D-dimer in active malignancy and indicates increased thrombosis risk in active disease. Elevated D-dimer following anticoagulation for a thrombotic event indicates increased risk of recurrent thrombosis. These and other issues are addressed.
© 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  D-dimer; Deep venous thrombosis; Disseminated intravascular coagulation; Fibrinolysis; Pulmonary embolus

Mesh:

Substances:

Year:  2015        PMID: 25934358     DOI: 10.1016/bs.acc.2014.12.001

Source DB:  PubMed          Journal:  Adv Clin Chem        ISSN: 0065-2423            Impact factor:   5.394


  44 in total

1.  Perioperative D-dimer levels after transcatheter aortic valve replacement: Comparison of patients with and without anticoagulant therapy.

Authors:  Akihiro Tobe; Akihito Tanaka; Yoshiyuki Tokuda; Toshihiko Nishi; Yusuke Miki; Kenji Furusawa; Hideki Ishii; Akihiko Usui; Toyoaki Murohara
Journal:  Cardiol J       Date:  2020-11-03       Impact factor: 2.737

2.  Re-visiting D-dimers and fibrin degradation products for the diagnosis of acute aortic dissection.

Authors:  Chwan-Yau Luo; Jun-Neng Roan
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

3.  Risk factors of pulmonary embolism in the elderly patients: a retrospective study.

Authors:  Yuxia Ma; Yi Liu; Ying Zhi; Haibin Wang; Mei Yang; Jieting Niu; Li Zhao; Pengsheng Wang
Journal:  Aging Clin Exp Res       Date:  2022-01-10       Impact factor: 3.636

4.  Systemic embolism with left atrial thrombus occurring four years after left atrial appendage closure in a patient with atrial fibrillation.

Authors:  Zhi-Hong Zhao; Sai-Hua Wang; Qiang Huan; Luo-Ning Zhu; Zhong-Ping Ning
Journal:  World J Emerg Med       Date:  2022

5.  Reference Intervals of Routine Coagulation Assays During the Pregnancy and Puerperium Period.

Authors:  Jiao-Mei Gong; Yong Shen; Yan-Xia He
Journal:  J Clin Lab Anal       Date:  2016-04-07       Impact factor: 2.352

6.  Plasminogen Activator Inhibitor-1 Reduces Tissue-Type Plasminogen Activator-Dependent Fibrinolysis and Intrahepatic Hemorrhage in Experimental Acetaminophen Overdose.

Authors:  Asmita Pant; Anna K Kopec; Kevin S Baker; Holly Cline-Fedewa; Daniel A Lawrence; James P Luyendyk
Journal:  Am J Pathol       Date:  2018-02-16       Impact factor: 4.307

Review 7.  The Function and Therapeutic Potential of Circular RNA in Cardiovascular Diseases.

Authors:  Kai Wang; Xiang-Qian Gao; Tao Wang; Lu-Yu Zhou
Journal:  Cardiovasc Drugs Ther       Date:  2021-07-16       Impact factor: 3.727

8.  Dominant role of αIIbβ3 in platelet interactions with cross-linked fibrin fragment D-dimer.

Authors:  Lorena Buitrago; Hina Zafar; Yixiao Zhang; Jihong Li; Thomas Walz; Barry S Coller
Journal:  Blood Adv       Date:  2020-07-14

9.  Prognostic value of D-dimer for adverse outcomes in patients with infective endocarditis: an observational study.

Authors:  Ying-Wen Lin; Mei Jiang; Xue-Biao Wei; Jie-Leng Huang; Zedazhong Su; Yu Wang; Ji-Yan Chen; Dan-Qing Yu
Journal:  BMC Cardiovasc Disord       Date:  2021-06-05       Impact factor: 2.298

10.  Markers of Prognosis for Early Stage Cervical Cancer Patients (Stage IB1, IB2) Undergoing Surgical Treatment.

Authors:  Chen Xu; Tie Ma; Hongzan Sun; Xiaohan Li; Song Gao
Journal:  Front Oncol       Date:  2021-06-02       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.